1 |
[GO] |
2025―Jan―08 |
Adverse Events Associated with Antivirals for COVID-19: An Analysis
Based on FDA Adverse Event Reporting System (FAERS) |
Muhammad Ikhwan Syahmi Mohamad Radzuan, Mahmathi Karuppannan |
2 |
[GO] |
2024―Sep―09 |
Parsonage-Turner Syndrome Following AstraZeneca COVID-19 Vaccination |
Maroua Slouma, Malek Dhifallah, Lobna Ben Ammar, Imen Gharsallah |
3 |
[GO] |
2023―Nov―30 |
Association of Cardiovascular Events with COVID-19 Vaccines using Vaccine
Adverse Event Reporting System (VAERS): A Retrospective Study |
Mohd Amir, S. Latha, Ruchika Sharma, Anoop Kumar |
4 |
[GO] |
2023―Aug―18 |
Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients |
Pramodini B. Kale-Pradhan, Regina Pacitto, Christopher A. Giuliano, Leonard B. Johnson |
5 |
[GO] |
2023―Jun―15 |
Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report |
Wiem Daly, Imen Aouintia, Ghozlane Lakhoua, Widd Kaabi, Ons Charfi, Sana Debbeche, Sarrah Kastalli, Ahmed Zaiem, Sihem El Aidli |
6 |
[GO] |
2023―May―04 |
Side Effects Reported by Moroccan Medical Students Who Received COVID-19 Vaccines |
Badreddine Moukafih, Leila Belaroussi, Sanae Achour, Abdeslam El Kartouti |
7 |
[GO] |
2023―Apr―09 |
The Safety and Effectiveness of Antifungal Medications in the Management of Mucormycosis during the COVID-19 Pandemic |
Joseph M Pappachan, Dhanya Jose, Krishna S Nair, Alagesan Murali |
8 |
[GO] |
2023―Mar―31 |
Covid-19 vaccination program for children: An electronic assessment of symptoms |
Rohit Kamboj, Naman Kumar, Arjun Khora, Riya Loomba, Nikhil Sharma, Abhishek Kumar, Ajay Rana, Sweta Kamboj, Kumar Guarve, Surya Prakash Guatam |
9 |
[GO] |
2023―Mar―30 |
Myocarditis and Pericarditis related to mRNA COVID-19 Vaccination: A Case Report |
Elena María Pérez López, Diego Rangel Sousa, Jorge Navarro Roldán |
10 |
[GO] |
2023―Jan―19 |
Perception and practices of self-medication practices among health science students during the ongoing COVID-19 pandemic in Mangalore, India |
Nitin Joseph, Jeniya Jain |
11 |
[GO] |
2022―Sep―29 |
Need for focused pharmacovigilance in the face of rapid COVID-19 vaccine development |
Sankha Shubhra Chakrabarti, Upinder Kaur |
12 |
[GO] |
2022―Aug―04 |
Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An observational study |
Dhanya Jose, Nitin Dhupdale, Jagadish A. Cacodcar, Umesh Kamat |
13 |
[GO] |
2022―Aug―02 |
Efficacy of Sinopharm Vaccine among Stem Cell Transplant Recipient during two peaks of Delta and Omicron variants of COVID-19 |
Ali Ghasemi, Rozita khodashahi, Mohsen Aliakbarian, Ebrahim Khaleghi, Baran Razmkhah, Mehrsa Vahdatinia, Mahdi Salimi Far, Omolbanin Bakhti |
14 |
[GO] |
2022―Jun―21 |
Impact Of The Vaccination Against Covid-19 On Frontline Health Workers |
Marcello M. C. Magri, David E Uip, Flaviane K. Rodrigues, Elisangela R. Lima, Glaucia L. da Veiga, Beatriz da C. A. Alves, Thaís Gascón, Ana C. M. Gaiatto, Thaciane A. Bibo, Nicolle de Godoy Moreira e Costa, Fernando Luiz Affonso Fonseca |
15 |
[GO] |
2022―Jun―15 |
A case of de novo annular-plaque type psoriasis following Oxford-AstraZeneca COVID-19 vaccination |
Namrata Chhabra, Anju George C |
16 |
[GO] |
2022―May―20 |
Critical Clinical Evaluation of Covid-19 Patients with Tuberculosis in the Indian Sub-Continent |
Hemalatha Selvaraj, Kumudha Damadarosamy, Kiruthiga Natarajan, K. Reeta Vijaya Rani, Kanagaraj Duraisamy, Rachel Parise, Muralikrishnan Dhanasekaran, Jack Deruiter, Jun Ren, Sivakumar Thangavel |
17 |
[GO] |
2022―May―16 |
Perception and self-medication practices among the general population during the ongoing COVID-19 pandemic in Mangalore, India |
Nitin Joseph, Sumith Marian Colaco, Ronel Valentine Fernandes, Sarvesh G. Krishna, Sourav I Veetil |
18 |
[GO] |
2022―May―11 |
Hyper-eosinophilic syndrome with myocarditis after inactivated SARS-CoV-2 vaccination - a case study |
Ashutosh Tiwari, Gaurav Karna, Sankha Shubhra Chakrabati, Prasan Kumar Panda, Upinder Kaur |
19 |
[GO] |
2022―Apr―30 |
Self-Medication during the Era of COVID-19; Potential Implications for Drug Policy Makers and Pharmacovigilance |
Tauqeer Hussain Mallhi, Yusra Habib Khan, Muhammad Hammad Butt, Muhammad Salman |
20 |
[GO] |
2022―Apr―27 |
An investigation on self-medication practice during COVID-19 pandemic among Indian population |
Rohit Kamboj, Sweta Kamboj, Priyanka Kriplani, Kumar Guarve, Anuj Joginath, Sachin Kumar, Surya Prakash Guatam |
21 |
[GO] |
2022―Apr―06 |
Artificial Intelligence in Pharmacovigilance and Covid-19 |
Kamini Bhardwaj, Rabnoor Alam, Ajay Pandeya, Pankaj Kumar Sharma |
22 |
[GO] |
2022―Apr―06 |
Coronavirus Disease 2019 and Hypertension: How Anti-Hypertensive Drugs Affect COVID-19 Medications and Vice Versa |
Aida Doostkam, Alireza Hosseinpour, Kamyar Iravani, Leila Malekmakan, Abdolreza Haghpanah, Fatemeh Masjedi, Zeinab Karimi, Hossein Rouzbeh, Jamshid Roozbeh |
23 |
[GO] |
2022―Mar―29 |
Use of Polypharmacy and Emergence of COVID-19 Variants - Is It Co-Related? |
Mayank Agarwal, Prasan Kumar Panda |
24 |
[GO] |
2022―Mar―18 |
Clinical Outcomes of Zinc Supplementation Among COVID-19 Patients |
Andrew D. Berti, Pramodini B. Kale-Pradhan, Christopher A. Giuliano, Bianca N. Aprilliano, Christopher R. Miller, Basma T. Alyashae, Ashish Bhargava, Leonard B. Johnson |
25 |
[GO] |
2022―Feb―09 |
Active Symptom-Based Surveillance of Adverse Events Following Immunization among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala |
Maria Jose, Priyanka Rajmohan, Joe Thomas, Swathi Krishna, Beena Antony, Unnikrishnan U G, Elsy M I, Raphael M P, Ponnu Jose, Lucy Raphael, Praveenlal Kuttichira |
26 |
[GO] |
2021―Dec―01 |
Clozapine and COVID-19: A Case Report and Clinical Considerations |
Dylan Lahiff, Peggy Chatham, Gregory Sullivan, Adam J. Fusick |
27 |
[GO] |
2021―Oct―23 |
Famotidine Possible Cutaneous Rash in Covid-19 Patients: An Adverse Effect Case Series |
Mohammadreza Salehi, Hossein Khalili, Zahra Jahani, Mehrnaz Rasoolinegad, Fereshte Ghiasvanad |
28 |
[GO] |
2021―Jul―29 |
A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients |
Mahanjit Konwar, Miteshkumar Maurya, Debdipta Bose |
29 |
[GO] |
2021―Jul―29 |
Assessment of COVID-19 treatment advised in different ethnic populations |
B Arjun, P R Krishnendu, S M Zachariah, L K Pappachen |
30 |
[GO] |
2021―Jul―28 |
Hydroxychloroquine and Azithromycin Combination in The Management of COVID-19 Infection: Safety and Effectiveness Challenges |
Ahmed Essam Abou Warda, Mahmoud Tammam, Rabab Ahmed El-Gazar, Rania Mohammad Sarhan, Sayed Gaber |
31 |
[GO] |
2021―Jul―28 |
COVID-19: Are Experimental Drugs Cure or Ill? |
Bensu Karahalil, Aylin Elkama |